Analyst Ratings for Cleveland BioLabs (CBLI)
CBLI Rating Summary
CBLI Price Target Summary
- Highest: $8.00 (Rodman & Renshaw)
- Lowest: $3.00 (Oppenheimer)
- Average: $4.75
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.75 (+196.9%)
Avg. $ Target:
$4.75 (+196.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/21/2013 | Cantor Fitzgerald | New Coverage | Buy (N/A) |
4.00 (N/A) |
1.79 | 1.60 | -10.61% | Details |
| 12/6/2012 | Oppenheimer | New Coverage | Outperform (N/A) |
3.00 (N/A) |
1.40 | 1.60 | 14.29% | Details |
| 12/4/2012 | Burrill | New Coverage | Market Outperform (N/A) |
4.00 (N/A) |
1.31 | 1.60 | 22.14% | Details |
| 3/14/2012 | Rodman & Renshaw | New Coverage | Market Outperform (N/A) |
8.00 (N/A) |
3.14 | 1.60 | -49.04% | Details |
| 2/2/2011 | Wedbush | New Coverage | Outperform (N/A) |
N/A (N/A) |
6.60 | 1.60 | -75.76% | Details |
| 7/21/2010 | WBB Securities | Downgrade | Buy (N/A) |
N/A (N/A) |
3.26 | 1.60 | -50.92% | Details |
